Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 109, Issue 9, 2015, Pages 1147-1154

  Benson, Victoria S ^a   Müllerová, Hana ^a   Vestbo, Jørgen ^b   Wedzicha, Jadwiga A ^c   Patel, Anant ^d   Hurst, John R ^d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Cohort study; Epidemiology; Gastro oesophageal reflux disease

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FUNCTIONAL RESIDUAL CAPACITY; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; INSPIRATORY CAPACITY; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; TREATMENT OUTCOME; AGED; COMORBIDITY; ENGLAND; KAPLAN MEIER METHOD; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COMORBIDITY; ENGLAND; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PREVALENCE; PROTON PUMP INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS;

EID: 84941736297     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.06.009     Document Type: Article

References (18)

1. Global Initiative for Chronic Obstructive Lung Disease. Documents and Resources. http://www.goldcopd.org/Guidelines/guidelines-resources.html 2014 [cited 15 A.D. Mar 10].
2. T.S. Ingebrigtsen, J.L. Marott, J. Vestbo, B.G. Nordestgaard, J. Hallas, and P. Lange Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease Respirology 20 2015 101 107
3. C.H. Martinez, Y.F. Okajima, S. Murray, G. Washko, G.R. Washko, F. Martinez, F.J. Martinez, E. Silverman, E.K. Silverman, J.H. Lee, J.H. Lee, E. Regan, E.A. Regan, J. Crapo, J.D. Crapo, J. Curtis, J.L. Curtis, H. Hatabu, H.F. Hatabu, and M.K. Han Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort Respir. Res. 15 2014 10.1186/1465-9921
4. T. Sasaki, K. Nakayama, H. Yasuda, M. Yoshida, T. Asamura, T. Ohrui, H. Arai, J. Araya, K. Kuwano, and M. Yamaya A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients J. Am. Geriatr. Soc. 57 2009 1453 1457
5. J. Vestbo, W. Anderson, H.O. Coxson, C. Crim, F. Dawber, L. Edwards, G. Hagan, K. Knobil, D.A. Lomas, W. MacNee, E.K. Silverman, and R. Tal-Singer Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) Eur. Respir. J. 31 2008 869 873
6. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, R. Tal-Singer, B. Miller, D.A. Lomas, A. Agusti, W. MacNee, P. Calverley, S. Rennard, and et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease N. Engl. J. Med. 363 2010 1128 1138
7. R.G. Barr, B.R. Celli, D.M. Mannino, T. Petty, S.I. Rennard, F.C. Sciurba, J.K. Stoller, B.M. Thomashow, and G.M. Turino Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD Am. J. Med. 122 2009 348 355
8. B. Mokhlesi, A.L. Morris, C.F. Huang, A.J. Curcio, T.A. Barrett, and D.W. Kamp Increased prevalence of gastroesophageal reflux symptoms in patients with COPD Chest 119 2001 1043 1048
9. A.R.C. Patel, and J.R. Hurst Gastro-oesophageal reflux disease and COPD Eur. Respir. Monogr. Charlesworth Gr. 2014 1 10
10. R.M. Zagari, L. Fuccio, M.A. Wallander, S. Johansson, R. Fiocca, S. Casanova, B.Y. Farahmand, C.C. Winchester, E. Roda, and F. Bazzoli Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study Gut 57 2008 1354 1359
11. K. Alexandropoulou, V.J. van, F. Reid, A. Poullis, and J.Y. Kang Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study Eur. J. Gastroenterol. Hepatol. 25 2013 15 21
12. G.S. Gaude Pulmonary manifestations of gastroesophageal reflux disease Ann. Thorac. Med. 4 2009 115 123
13. Y.H. Lin, C.L. Tsai, L.N. Chien, H.Y. Chiou, and C. Jeng Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis - a nationwide population-based cohort study Int. J. Clin. Pract. 69 2015 350 357
14. K. Terada, S. Muro, S. Sato, T. Ohara, A. Haruna, S. Marumo, D. Kinose, E. Ogawa, Y. Hoshino, A. Niimi, T. Terada, and M. Mishima Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation Thorax 63 2008 951 955
15. E. Ozyilmaz, N. Kokturk, G. Teksut, and T. Tatlicioglu Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease Int. J. Clin. Pract. 67 2013 691 697
16. J. Kim, J.H. Lee, Y. Kim, K. Kim, Y.M. Oh, K.H. Yoo, C.K. Rhee, H.K. Yoon, Y.S. Kim, Y.B. Park, S.W. Lee, and S.D. Lee Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study BMC Pulm. Med. 13 2013 51
17. I.E. Rascon-Aguilar, M.F. Pamer, P.F. Wludyka, J.F. Cury, D.F. Coultas, L.R. Lambiase, N.S. Nahman, K. Vega, and K.J. Vega Role of gastroesophageal reflux symptoms in exacerbations of COPD Chest 130 2006 1096 1101
18. J.T. Ramos, J. Saavedra, and J. Ruiz-Contreras Cryptosporidium in patients infected with human immunodeficiency virus: azithromycin revisited J. Pediatr. 130 1997 1009 1010